Skip to main content
Figure 2 | Critical Care

Figure 2

From: The metabolic and renal effects of adrenaline and milrinone in patients with myocardial dysfunction after coronary artery bypass grafting

Figure 2

Plasma glucose and insulin doses. The time course of plasma glucose (a) and insulin (b) doses in patients with myocardial dysfunction after coronary artery bypass grafting surgery, treated with adrenaline (n = 7) or milrinone (n = 11), and in control patients (n = 20) not needing inotropic support. Data are given as mean ± standard error of the mean. aSignificant difference (p < 0.05) in comparison with baseline values (paired t test); bsignificant difference (p < 0.05) in comparison with the control group (analysis of variance [ANOVA] with post hoc Fisher's predicted least-square difference [PLSD]); csignificant difference (p < 0.05) between the adrenaline and the milrinone group (ANOVA with post hoc Fisher's PLSD).

Back to article page

Critical Care

ISSN: 1364-8535